Cited by 58Metabolism and Genetic DisordersFetal and Pediatric Neurological DisordersNeurological diseases and metabolism

Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients

Weller, S., Rosewich, H., Gärtner, J.·2008·Journal of Inherited Metabolic Disease

Abstract

Patients with defects in the biogenesis of peroxisomes include those with Zellweger syndrome spectrum (ZSS), a developmental and progressive metabolic disease with a distinct dysmorphic phenotype and varying severity. The diagnosis of ZSS relies on the clinical presentation and the biochemical evaluation of peroxisomal metabolites. Mutation detection in one out of twelve genes coding for proteins involved in the biogenesis of peroxisomes confirms the diagnosis. In the absence of pronounced clinical features of ZSS, neuroradiological findings may lead the way to the diagnosis. Cerebral magnetic resonance imaging (cMRI) pathology in ZSS consists of abnormal gyration pattern including polymicrogyria and pachygyria, leukencephalopathy, germinolytic cysts and heterotopias as reported by previous systematic studies including cMRI of a total of 34 ZSS patients, only five of whom had a severe phenotype. The present study evaluated the cMRI results of additional 18 patients, 6 with a severe and 12 with a milder ZSS phenotype. It confirms and extends knowledge of the characteristic cMRI pattern in ZSS patients. Besides an abnormal gyration pattern and delayed myelination or leukencephalopathy, brain atrophy was a common finding. Polymicrogyria and pachygyria were more common in patients with severe ZSS, while leukencephalopathy increases with age in patients with longer survival. Nevertheless, an abnormal gyration pattern might be more frequent in patients with a mild ZSS than deduced from previous studies. In addition, we discuss the differential diagnosis of the ZSS cMRI pattern and review investigations on the pathogenesis of the ZSS cerebral phenotype in mouse models of the disease.

Integrity signals

Registry

Crossref · 10.1007/s10545-008-0856-3

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In some PBD cases, mild initial symptoms are later followed by severe CNS demyelination and death.

    “In some cases, mild initial symptoms are later followed by severe CNS demyelination and death of the patient [53,55,56].”

    From Peroxisomes in brain development and function (2016) · cites this paper as [53]

  • Within their first year of life, all patients with Zellweger syndrome display white matter abnormalities in the CNS, observed by histological analyses and brain magnetic resonance tomography.

    “In addition to these migration defects, within their first year of life, all patients with Zellweger syndrome display white matter abnormalities in the CNS, which have been observed by histological analyses and brain magnetic resonance tomography (MRT) studies [52–55].”

    From Peroxisomes in brain development and function (2016) · cites this paper as [53]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Weller, S., Rosewich, H., & Gärtner, J.
Affiliations
  • Department of Pediatrics and Pediatric Neurology Georg August University Robert‐Koch‐Strasse 40 Göttingen 37075 Germany
  • University of Göttingen (DE)
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2008-04
Volume
31
Issue
2
Pages
270-280
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W2050837335
Cited by
58
References
48
Citations by year
2026: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 6 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 7 · 2015: 6 · 2014: 3 · 2013: 3 · 2012: 7
FWCI
1.76
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
  • GRO (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (GA354/5–1, 5–2)
  • Fritz Thyssen Stiftung (Az.10.05.2.197)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
peroxisome biogenesis disorders, brain MRI, polymicrogyria, pachygyria, leukoencephalopathy, heterotopia, brain atrophy, delayed myelination, differential diagnosis, mouse model, peroxisomal disorders
MeSH terms
Animals, Brain, Child, Preschool, Diagnosis, Differential, Disease Models, Animal, DNA Mutational Analysis, Humans, Infant, Infant, Newborn, Magnetic Resonance Imaging, Mutation, Phenotype, Predictive Value of Tests, Prognosis, Severity of Illness Index, Zellweger Syndrome, Genetic Predisposition to Disease, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review